We accept no liability for the result of any action taken on the basis of the Information or for any loss from use of this webpage. London Stock Exchange, the London Stock Exchange coat of arm device are trademarks of London Stock Exchange plc....
AZNU.K.: London Watchlist You must be logged in to create alerts Closed Last Updated:Jan 7, 2025 4:39 p.m.GMTDelayed quote p10,668 -44-0.41% Previous Close 10,712p Toggle Chart Options Advanced Charting Range Dropdown Volume: 1.18M65 Day Avg: 2.57M ...
(CAT) Group.The offer,which equates to 1,320 pence per CAT share,represents a 66.9% premium on the closing mid-market price (791 pence) of CAT's shares on the London Stock Exchange and an 88.0% premium on the average share price (702 pence) over the last 12 months.CAT reported an...
AstraZeneca's share price was however down 2.28 percent in mid-afternoon trading in London. Britain, whose widely-praised vaccine rollout has been largely underpinned by the AstraZeneca jab, also defended it as "both safe and effective", while Sweden and the Netherlands said they would continue ...
AstraZeneca PLC is one of the world's leading pharmaceutical companies. Its corporate headquarters are in London, its research and development headquarters are in Södertälje, Sweden, and it has manufacturing facilities in 19 different countries. The company operates nine research and development si...
Stock Market: London Stock Exchange - LSE Currency: Penny sterling - GBX businessAstraZeneca Company Profile AZN - Stock Indices FTSE 100 FTSE 350 FTSE All-Share 1 Year Return ▲+3.29% file_download Daily closing prices, with moving averages and volumes - Penny sterling (GBX) ...
AstraZeneca AstraZeneca PLC Public LSE, NYSE and OMX: AZNFounded6 April 1999 by mergerHeadquartersLondon, England, UKKey peopleDavid Brennan CEOTony Zook
Date Type Shareholder Title Transaction Type Share Price Shares Value May 5, 2023 Sale Aradhana Sarin Disposition $74.81 PER SHARE 19,470 $1,456,551 Apr 28, 2023 Purchase Michel Demaré Acquisition $117.01 PER SHARE 2,000 $234,020 Mar 23, 2023 Purchase Pascal Soriot Derivative/Non-deriv...
“This probably tells you that our investors have confidence in not just the nearterm trajectory but the longer term,” and “there is excitement about the pipeline opportunities,” he adds. The share price has grown from £30 around 10 years ago to more than £120 on the London Stock...
But with government spending cuts and the sluggish economy creating a tough climate, analysts think AstraZeneca will be forced to do one or more midsized acquisitions to fill future revenue gaps. Possible targets include faster-growing rivals, such as London-listed Shire, or Amlin in the US, ...